Gene: TRIM35
Official Full Name: tripartite motif containing 35provided by HGNC
Gene Summary: The protein encoded by this gene is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. The function of this protein has not been identified. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO04401 | TRIM35 Knockout cell line (HeLa) | Human | TRIM35 | 1:3~1:6 | Negative | Online Inquiry |
KO04402 | TRIM35 Knockout cell line (HCT 116) | Human | TRIM35 | 1:2~1:4 | Negative | Online Inquiry |
KO04403 | TRIM35 Knockout cell line (HEK293) | Human | TRIM35 | 1:3~1:6 | Negative | Online Inquiry |
KO04404 | TRIM35 Knockout cell line (A549) | Human | TRIM35 | 1:3~1:4 | Negative | Online Inquiry |
TRIM35 Gene Knockout Cell Lines are specialized cellular models engineered through targeted gene editing techniques to abrogate the expression of the TRIM35 gene, which is associated with various cellular regulatory processes and signaling pathways. These knockout cell lines enable researchers to study the specific roles and functions of TRIM35 in cellular biology, providing insights into its involvement in important mechanisms such as immune response modulation, inflammation regulation, and tumorigenesis.
The primary function of TRIM35 lies in its role as an E3 ubiquitin ligase, which is integral to the post-translational modification of proteins, influencing protein stability and function. By utilizing TRIM35 Gene Knockout Cell Lines, investigators can dissect pathways influenced by TRIM35, analyze the impact on downstream signaling, and observe phenotypic variations compared to wild-type controls. These lines serve as a powerful tool for elucidating the biological implications of TRIM35 dysregulation, offering a platform for potential therapeutic advancements.
From a scientific and clinical perspective, these knockout cell lines are invaluable resources for cancer research and the study of autoimmune diseases, contributing to the discovery of novel drug targets and therapeutic strategies. With the growing interest in targeted therapies driven by an understanding of molecular genetics, TRIM35 Gene Knockout Cell Lines stand at the forefront of innovative research.
What sets these cell lines apart from alternatives is their high specificity and consistent performance, providing researchers with reliable and reproducible results. Additionally, our commitment to rigorous quality control ensures that each line is meticulously validated for gene editing efficiency and tissue-specific expression.
Investing in TRIM35 Gene Knockout Cell Lines equips researchers and clinicians with a critical asset for advancing their studies, ultimately leading to breakthroughs that could transform clinical applications. Our company specializes in delivering cutting-edge biological products, and we take pride in our expertise and ability to support the scientific community with innovative solutions tailored to enhance research outcomes.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.